Successful Treatment with Atezolizumab Combination Chemotherapy in a Patient with High‐grade Fetal Adenocarcinoma of the Lung: A Case Report
Thoracic cancer(2022)
摘要
High-grade fetal lung adenocarcinoma (H-FLAC) is a rare tumor, with little known of its response to chemotherapy with or without an immune checkpoint inhibitor or of its molecular profile. We report the first case of a 56-year-old man with stage IV H-FLAC who was successfully treated with carboplatin plus nab-paclitaxel in combination with atezolizumab. In addition, the tumor was found to be positive for amplification of the human epidermal growth factor receptor 2 gene.
更多查看译文
关键词
atezolizumab,case report,high-grade fetal lung adenocarcinoma (H-FLAC),human epidermal growth factor receptor 2 (HER2,ERBB2),immunotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要